BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13695801)

  • 1. [On the pathogenesis and therapy of Wilson's disease. The effect of alpha-lipoic acid (preliminary communication)].
    da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
    Arzneimittelforschung; 1960 May; 10():333-9. PubMed ID: 13695801
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiments on the pathogenesis of Wilson's disease. 4. The action of alpha-lipoic acid on the metabolism of copper and proteins in cases of hepatolenticular degeneration (recent observations)].
    da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
    Gaz Med Port; 1960; 13():706-22. PubMed ID: 13695799
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the biochemical pathology of Wilson's disease. New observations on the action of alpha-liponic acid].
    da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
    Arzneimittelforschung; 1961 May; 11():438-44. PubMed ID: 13695800
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the therapy of Wilson's disease].
    da COSTA S; da SILVA J
    Arzneimittelforschung; 1963 Apr; 13():280-2. PubMed ID: 14023283
    [No Abstract]   [Full Text] [Related]  

  • 5. The electroencephalogram in hepatolenticular degeneration (Wilson's disease).
    HELLER GL; KOOI KA
    Electroencephalogr Clin Neurophysiol; 1962 Aug; 14():520-6. PubMed ID: 13906230
    [No Abstract]   [Full Text] [Related]  

  • 6. Some aspects of kidney function in hepatolenticular degeneration (Wilson's disease).
    HODGES RE; KIRKENDALL WM; GUBLER CJ
    J Lab Clin Med; 1956 Mar; 47(3):337-42. PubMed ID: 13295696
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function in Wilson's disease.
    BEARN AG; YU TF; GUTMAN AB
    J Clin Invest; 1957 Jul; 36(7):1107-14. PubMed ID: 13449163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Wilson's disease].
    Kovacević I; Zekan M
    Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
    Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
    Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pure hepatic form of Wilson's disease in an infant; effect of therapy with chelators].
    FRANCOIS R; LARBRE F; NICOLAS ; MALLEIN ; RUITTON-UGLIENGO
    Rev Esp Pediatr; 1958; 14(80):179-94. PubMed ID: 13555098
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morbus Wilson and possible therapeutic significance of lipoic acid].
    Gomes da Costa SF
    Arzneimittelforschung; 1970 Sep; 20(9):1210-3. PubMed ID: 4922320
    [No Abstract]   [Full Text] [Related]  

  • 15. Presynaptic mechanisms underlying the alpha-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals.
    Wang SJ; Chen HH
    Neurochem Int; 2007 Jan; 50(1):51-60. PubMed ID: 16949179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in antioxidant capacity of the guinea pig exposed to noise and the protective effect of alpha-lipoic acid against acoustic trauma].
    Diao MF; Liu HY; Zhang YM; Gao WY
    Sheng Li Xue Bao; 2003 Dec; 55(6):672-6. PubMed ID: 14695484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should it be safer to use a redox couple, both with (R)-alpha-lipoic acid combined with (R)-dihydrolipoic acid for avoiding prooxidant action of alpha-lipoic acid?
    Cakatay U
    Med Hypotheses; 2007; 68(5):1178. PubMed ID: 17134844
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychosis and Wilson's disease: a case report.
    Jukić I; Titlić M; Tonkić A; Dodig G; Rogosić V
    Psychiatr Danub; 2006 Jun; 18(1-2):105-7. PubMed ID: 16804509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mania as the first manifestation of Wilson's disease.
    Machado AC; Deguti MM; Caixeta L; Spitz M; Lucato LT; Barbosa ER
    Bipolar Disord; 2008 May; 10(3):447-50. PubMed ID: 18402634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.